BioSpace News Archive

Drug Development

SELLAS Life Sciences’ Highly Selective CDK9 Inhibitor, GFH009, Demonstrates Cancer Cell Growth Inhibition in Preclinical In Vitro Model of Neuroendocrine Prostate Cancer Cell Line

SELLAS Life Sciences Group, Inc. today announced results from a new preclinical in vitro study for its highly selective CDK9 inhibitor, GFH009, in neuroendocrine prostate cancer (NEPC).

August 24, 2022
·
5 min read
Business

Biote Appoints Samar Kamdar as Chief Financial Officer

biote Corp. (“Biote” or the “Company”), a high growth, differentiated medical practice-building business within the hormone optimization space, today announced that it has appointed Samar Kamdar as its Chief Financial Officer.

August 24, 2022
·
5 min read
Biotech Bay

Synthetic Medical Imaging: How Deepfakes Could Improve Healthcare

Retrace, a leader in dental artificial intelligence and provider of digital infrastructure for U.S. healthcare, announces the publication, “A generative adversarial inpainting network to enhance prediction of periodontal clinical attachment level” in the August 2022 Edition of the Journal of Dentistry.

August 24, 2022
·
3 min read
FDA

Calyptus Pharmaceuticals Announces Approval of Arformoterol Tartrate Inhalation Solution, EQ 0.015 mg Base/2 ml

Calyptus Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (“FDA”) granted approval to an Abbreviated New Drug Application (ANDA) for a generic version of Brovana.

August 24, 2022
·
1 min read
BioMidwest

ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of imaging technologies and Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the European Patent Office has issued European Patent No. 3730041 (the ‘041 patent) to ENDRA titled “System for Estimating Fractional Fat Content of an Object.”

August 24, 2022
·
4 min read
Business

Ansys and AMD Collaborate to Speed Simulation of Large Structural Mechanical Models Up to 6x Faster

Ansys (NASDAQ: ANSS) announced that Ansys® Mechanical™ is one of the first commercial finite element analysis (FEA) programs supporting AMD Instinct™ accelerators, the newest data center GPUs from AMD.

August 24, 2022
·
3 min read
AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with Avego

AtomVie Global Radiopharma Inc. today announced the successful closing of its Series A financing with Avego Management, LLC.

August 24, 2022
·
3 min read
Business

ValenzaBio Appoints Industry Veteran Peter Greenleaf to its Board of Directors

ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb) therapeutics for autoimmune and inflammatory indications, today announced the appointment of Peter Greenleaf to its board of directors.

August 24, 2022
·
2 min read
Business

Astrotech Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals

Astrotech Corporation (Nasdaq: ASTC) (the “Company”) announced its plans to hold its fiscal year 2022 annual meeting of stockholders (the “2022 Annual Meeting”) on Tuesday, November 15, 2022.

August 24, 2022
·
5 min read
Biotech Beach

Bacterial Biofilms, Responsible for Up to 75% of All Infectious Diseases in America, Explored in New Webinar From Quidel Corporation

The National Institutes of Health reports that bacterial biofilms are responsible for up to 75% of all infectious diseases in humans, including infections of wounds, the lungs and the urinary tract.

August 24, 2022
·
3 min read